BTC $ 8,644.89 -4.87785%
ETH $ 165.46 -6.13974%
MARKET CAP $ 237 bln -4.67%
ICOs 5,673

Stem Cell

ICO Ended
10,301 Views
At SCI, we are devoted to the international research, development, and implementation of stem cell therapy. We are also expanding our network with professionals, labs, clinics, hospitals, and nonprofit organizations. Our ultimate goal at SCI is to connect people who need treatment with the right dedicated solutions and professionals for their unique needs. At SCI, we believe such connections should be convenient and at your fingertips, just as so many other services are in modern society. We imagine a world where each and every person, no matter where they come from, will be able to connect with a Stem Cel Specialist instantly through our Stem Cell Innovations application (SCI Application), and in the same connection be able to decide when and how much confidential information to share with professionals.
8.8
TOTAL SCORE
8.1
ICO PROFILE

(weight: 45%)

9
SOCIAL ACTIVITY

(weight: 35%)

10
TEAM PROOF

(weight: 20%)

Get widget
General
Website: Visit
White paper: Read
Pre-sale Time: 17 Sept 2018 - 09 Oct 2018
ICO Time: 21 Nov 2018 - 17 Jan 2019
Whitelist/KYC: KYC
Country: Gibraltar
Token info
Ticker: SCI
Platform: Ethereum
Token Type: ERC20
Available for sale: 800,000,000 SCI
Financial
ICO Price: 1 SCI = 0.15 USD
Accepting: BTC, ETH, LTC, Fiat
Soft cap: 3,000,000 USD
Hard cap: 36,000,000 USD
2013
Establishment of Camden RAD, LLC, a company devoted to stem cell research and development.
Q4 2017
Camden RAD, LLC is rebranded as Stem Cell Innovations, and a new company is established, based on blockchain technology.

Advanced research begins to determine market and development opportunities.
Q1 2018
Attended Token 2049 conference in Hong Kong.

Attended Stem Cell Summit at the University of California in Los Angeles (UCLA).

Attended CBC conference in San Francisco, CA.
Q2 2018
Attended ICO20 Summit in Santa Monica, CA.

Integration of smart contract technology is established.

Company headquarters incorporated in Gibraltar, GB.

Strategic efforts toward development begins.

Interviews with potential medical participants take place.
Q3 2018
Whitelist is scheduled to go live.

Token Sale starts.
Q4 2018
Token Sale ends and min max caps are assessed.

Distribution of Tokens to participants through ERC20 will commence.
Q1 2019
SCI will begin final testing and reporting based on blockchain technology being used.

Creation of a non-identical patient identification factor on Passive Blockchain Node will be initialized.

Demo testing for SCI Application v 1.0 will begin.
Q2 2019
Release of the SCI Application v1.1

Enrollment begins for doctors, patients, and stem cell laboratories in the United States
Q3 2019
Release of Market Surveillance strategy for further growth

Release SCI Application v2.0

Enrollment begins for professionals, patients, and stem cell laboratories in Middle East and across North Africa.

Announcement of first SCI Lab location and franchise expansion plan.
Q4 2019
Announcement of clinical development and research strategy in the stem cell field.

Public announcement regarding SCI achievements to date.

First ever online synthetic stem cell purchase through the SCI Application. Release SCI Application v3.0, fully functional platform for professionals and patients.
Q1 2020
Stem Cell Lab Evaluation report per first year of operation and development.

Release SCI earnings and financials report.

Release results of SCI's stem cell research and development to date.
Q2 2020
Expansion of SCI stem cell labs and clinics in China, Japan, South Korea, and India.

Begin charging membership fees (payable in Stem Cell Innovations tokens) for professional-facing portion of SCI application.
Q3 2020
Begin second phase of SCI stem cell research and development.

Release SCI Application v3.5, including professional-facing component to help practitioners become more involved in the stem cell research space and contribute to the network.
Q4 2020
Expansion and acquisition of SCI stem cell labs and clinics in Europe.
Q1 2021
Release SCI earnings and financials report for second year operation and development.

Release public update on SCI stem cell research and development.

Stem Cell Lab Evaluation report for second year.
Q2 2021
Release SCI Application v4.0 including:

A new platform for medical students, universities, and hospitals to engage with the SCI Application.

Fully Functional EMR Worldwide Enforcing HIPPA and expanding of synthetic stem cell delivery to Latin America.
Screenshots taken 13 Sep 2018
Moe Galal
Chief Executive Officer / Founder
Takes part in this project only
Ben Barel
Chief Operations Officer / Co-Founder
Takes part in this project only
Ali Alrashidi
Chief Technology Officer / Co-Founder
Takes part in this project only
Matt Galal
Chief of Staff / Co-Founder
Takes part in this project only
Kobi Barel
Operations Engineer / Co-Founder
Takes part in this project only
John Glavinovich, M.D.
Medical Director
Takes part in this project only
Philip Glukhovsky, D.C.
Health Informatics Manager
Takes part in this project only
Roger Williams
VP of Marketing
Takes part in this project only
Liz Curlett
VP, PR & Corporate Communications
Takes part in this project only
Candice Kouchache
Business Development
Takes part in this project only
Ahmed Elsantawi
VP of International Human Resources
Takes part in this project only
David Marmon
Web Designer
Takes part in this project only
Heather Deveaux
Copywriter
Takes part in this project only
Everlecia Taylor
Creative Writer
Takes part in this project only
Marina Evglevskaya
Administrative Manager
Takes part in this project only
Rakel Apodaca
Product Manager
Takes part in this project only
Michelle Chavon
Marketing
Takes part in this project only

Advisors (7)

Boyan Josic
Participates in a number of projects
Marc X. Ellul
Participates in several projects
Roger Shortz, M.D.
Takes part in this project only
Greg Maddex, D.O
Takes part in this project only
Pantea Nakieen, M.D.
Takes part in this project only
Shahab Sajadi
Takes part in this project only
Igor Soshkin
Participates in several projects
HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Active
Liqio Exchange
LIQIO is an Estonian registered company (LIQIO OÜ 1478949). The company has an address in Estonia and offices in Western Europe. When you purchase LQO tokens, you will receive dividends once a month. 50% of the fees collected by the exchange will be paid to the holder of the LQO token. Community trading: follow the best traders In partnership with Shillerz.
Upcoming
Cryptelo
Cryptelo is a blockchain-based encryption technology company that provides data transfer, collaboration, versioning, and storage services. Cryptelo Platform technology combines encryption and blockchain based key management that allows for data mirroring. This means users can share data by giving access, without it ever leaving their hands, and no third party can access and read data without permission.
Active
COTI
COTI is the world’s first blockchain protocol optimized for decentralized payments, designed for use by merchants, governments, payment dApps and stable coin issuers. COTI Pay, our first app, already boasts a network of 5,000 merchants and 80,000 users. COTI uses a DAG (directed acyclic graph) ledger to address the shortcomings of blockchain platforms that make them unsuitable for supporting mainstream and everyday transactional needs.
Upcoming
Burency
Burency is an advocate for crypto and Blockchain adoption, particularly in the MIDDLE EAST. The platform is designed to address key challenges that prevent widespread adoption within the cryptocurrency and Blockchain ecosystem such as exchange’s lack of liquidity and security, unsustainable mining, unawareness of Blockchain applications to businesses. The Burency Exchange is a regulated exchange platform that addresses key challenges including security, liquidity, fiat to crypto transactions and vise versa, and more. The exchange is one of the world’s fully insured platforms, with coverage provided from LIoyd’s of London through the Nebbex Protocol. The Burency Mining facility answers some of the challenges associated with crypto mining such as mining destruction to environment and excessive mining power expenses by creating a sustainable facility powered by renewable hydropower. Burency provides a streamlined platform for the generation of cryptocurrency via purchased timeshare slots within the mining facilities using the BUY token. Additionally, computational power can also be purchased via the BUY token which governs purchases across the Burency ecosystem. The Burency Blockchain Development Center is dedicated mainly for advising enterprises on Blockchain applications and helping them operate on the blockchain for more efficient operation and business transactions execution. In particular, the center focuses on the creation of smart contracts that enable businesses to trade with entities across geographical and jurisdiction boundaries.
Upcoming
Escrowblock
The aim of the project is to create an EscrowBlock platform for the Ethereum network blockchain. Such a platform can work as an independent environment, or be integrated into other Smart contracts, to provide escrow services as part of any other projects. The team will start the project on Mainnet Ethereum blockchain and then make a fork for providing an independent service.
Active
Tempo
Tempo is a French licensed, Paris-based, European-wide anchor for Stellar blockchain payments. The company offers online, offline and digital backed remittances to nearly 100 destination countries with over 300 physical agent locations. Tempo is creating the easiest, fastest and most secure bridge between cash and crypto.